A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
 
Sponsors and Collaborators
Dana-Farber Cancer Institute
Children’s Hospital Boston
Advantagene, Inc.
 
Contact
Jessica L Lawlor, BA
617-632-5376
 
Investigator
Mark W Kieran, MD, PhD
Dana-Farber Cancer Institute
 
ClinicalTrials.gov Identifier